Alongside major movement in Congress to pass legislation to mitigate the negative impacts of certain pharmacy benefit manager practices on prescription drug costs, 43 states this year have also considered at least 137 reform bills to regulate the PBM industry, according to the National Academy for State Health Policy (NASHP). Of those, 21 bills have been enacted, 25 failed, and 91 are still pending in state legislatures. The contents of these bills range from extensive transparency requirements and the prohibition...